Authored By: Sarah
10 Aug 2024

 Synthetic Biology Market Size to grow by USD 55600.6 million between 2024-2028

According to a research report “ Synthetic Biology Market” by Application (Healthcare, Industrial, Food and agriculture, Others) Product (Oligonucleotides, Enzymes, Cloning technology kits, Xeno-nucleic acids, Chassis organism) Geography (North America, Europe, Asia, Rest of World (ROW))- Global Forecast to 2028 published by Technavio, the market size is estimated to grow by USD 55600.6 million, at a CAGR of 34.1% during the forecast period. In the burgeoning landscape of the global synthetic biology market, the technology's expanding applications are fueling its significant growth. Synthetic biology, an interdisciplinary field merging science and engineering, is revolutionizing industries such as agriculture, food and beverage (F&B), health and wellness, and energy. Notably, the F&B sector is experiencing a surge in synthetic biology adoption, with its utilization in producing fundamental food components. This cutting-edge technology enables the design and engineering of custom genes, offering enhanced efficiency for biochemicals, therapeutics, medicine, biofuels, and bio-based alternatives..

Browse market data tables, figures, and in-depth TOC on “Synthetic Biology Market” by Application (Healthcare, Industrial, Food and agriculture, Others) Product (Oligonucleotides, Enzymes, Cloning technology kits, Xeno-nucleic acids, Chassis organism) Geography (North America, Europe, Asia, Rest of World (ROW)) Global Forecast to 2028. Download Free Sample

By Application, the Healthcare segment is projected to dominate the market size in 2024

The Synthetic Biology market is experiencing significant growth due to the increasing demand for innovative solutions in various industries. This sector, which involves designing and engineering biological systems for useful purposes, offers substantial business opportunities. Companies are investing heavily in research and development to create novel products and processes, particularly in areas such as healthcare, agriculture, and energy. Synthetic Biology's potential to revolutionize industries through precision, efficiency, and sustainability makes it a lucrative and exciting area for businesses.

By Product, Oligonucleotides  segment is expected to hold the largest market size for the year 2024

The Synthetic Biology market is experiencing significant growth due to the increasing demand for innovative solutions in various industries. This sector, which involves designing and engineering biological systems for useful purposes, offers substantial business opportunities. Companies are investing heavily in research and development to create novel products and processes, leveraging advanced technologies such as gene editing, synthetic gene circuits, and metabolic engineering. The market's potential applications span from agriculture and healthcare to energy and materials production, making it a lucrative and dynamic business landscape.

North America is forecasted to hold the largest market size by region in 2024

The Synthetic Biology market represents a significant growth opportunity for businesses seeking to innovate and disrupt traditional industries. This sector encompasses the design, construction, and optimization of biological systems for useful purposes, leveraging advanced technologies such as gene editing, synthetic gene circuits, and metabolic engineering. Companies investing in Synthetic Biology can expect to reap rewards through the development of novel products, improved processes, and sustainable solutions.

The Synthetic Biology Market growth and forecasting report also includes detailed analyses of the competitive landscape of the market growth and forecasting and information about 20 market companies, including:

  • Agilent Technologies Inc.
  • Algenol
  • Amyris Inc.
  • CD Biosynsis
  • Codexis Inc
  • Creative Biogene
  • Danaher Corp.
  • Eurofins Scientific SE
  • Genomatica Inc.
  • GenScript Biotech Corp.
  • Ginkgo Bioworks Holdings Inc.
  • Illumina Inc.
  • Merck KGaA
  • New England Biolabs Inc.
  • Novozymes AS
  • Precigen Inc.
  • Sanofi SA
  • Synthego Corp.
  • Thermo Fisher Scientific Inc.
  • Twist Bioscience Corp.
.

For insights on company offerings- Request a sample report!

Research Analysis Overview

Synthetic Biology, a revolutionary branch of biotechnology, is transforming industries from healthcare to fashion, by enabling the design and construction of new biomolecules, medical devices, biomaterials, and even synthetic organisms. Biopharmaceutical companies are leveraging synthetic biology for drug discovery, RNA development, and gene-editing technologies like CRISPR-Cas9 for therapeutic genome editing. In the healthcare verticals, synthetic biology is also driving advancements in cellular recording, multiplexed diagnostics, and biosensors. Bolt Threads and Modern Meadow are pioneering the use of synthetic biology in fashion, producing biomaterials for sustainable textiles. Synthetic biology is also revolutionizing biofuel production, offering a sustainable alternative to fossil fuels. However, the rapid advancements in this field raise ethical, biosecurity, and biosafety concerns. Synthesizing synthetic DNA and performing DNA sequencing are key processes in synthetic biology, which are driving buying behavior in the market. The global synthetic biology market is expected to grow significantly in the coming years, as more industries discover the potential of this transformative technology.

Market Research Overview

Synthetic Biology, an interdisciplinary field that combines engineering and biology, is revolutionizing various industries, including pharmaceuticals, agriculture, and healthcare. Pharmaceutical investments in Synthetic Biology have surged due to its potential to reduce drug development costs and accelerate the discovery of novel therapeutics. This includes the development of vaccines, antibodies, therapeutic proteins, and living tissues through cellular engineering. Advancements in Synthetic Biology tools, such as 3D printing, regenerative medicine, and genome engineering, are enabling personalized treatments and advanced diagnostics. The use of synthetic biology in livestock and crop cultivation is also gaining traction, with applications ranging from biofuel production to genetically modified organisms. However, the Synthetic Biology market faces regulatory hurdles, ethical use concerns, and compliance difficulties. Ethical concerns surround the programming of cells, manipulation of biological pathways, and the creation of synthetic organisms. Regulatory agencies require proof of concept and rigorous testing before approving synthetic biology applications. Major players in the Synthetic Biology market include Sumitomo Chemical, Casdin Capital, and academic research institutions. Biopharmaceutical companies are also investing heavily in R&D, focusing on biomolecules, medical devices, biomaterials, and gene-editing technologies. The Synthetic Biology market is advancing technology in various healthcare verticals, including cancer, cystic fibrosis, and sickle cell anemia. Synthetic DNA, RNA development, and gene editing technology are key areas of focus. Synthetic biology is also being used in environmental applications, such as fuel alternatives and novel therapeutics. Despite the potential benefits, there are concerns surrounding the ethical use, biosafety, and biosecurity of synthetic organisms. Public perception and infrastructure and policies also play a role in the market concentration and growth of the Synthetic Biology industry. Innovative companies like DNA Script, Arbor Biotechnologies, SynBioBeta, Vitro Labs, Bolt Threads, Modern Meadow, and Creative Biogene are leading the way in synthetic biology applications, from Xeno-nucleic acids to cloning technology kits and enzymes. The synthetic DNA segment is a significant design objective, with machine learning and artificial intelligence playing a role in understanding biological phenomena. The Synthetic Biology market is also addressing healthcare issues, such as antibiotic-resistant superbugs, through the development of synthetic organisms and biomolecules. The future of synthetic biology lies in the creative application of technology to solve complex biological problems and improve our understanding of biological phenomena.

Contacts

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/

Read News Read Less
Interested in this report?
Get your sample now!

Safe and Secure SSL Encrypted

Technavio

  • 2500 USD

[5 reports/month/user]

  • 5000 USD

close
  • Basic Plan [5000 USD/Year]:

    Single User
    Download 5 Reports/Month
    View 100 Reports/Month
    Add upto 3 Users at 625 USD/user

  • Teams Plan [7500 USD/Year]:

    5 User
    Download 5 Reports/Month/User
    View 100 Reports/Month/User
    Add upto 30 Users at 500 USD/user

*You can upgrade to Teams plan at Subscription page

close
  • Single:

    One user only.
    Quick & easy download option

  • Enterprise:

    Unlimited user access (Within your organization).
    Complimentary Customization Included

*For Enterprise license, go to checkout page

Technavio Get the report (PDF) sent to your email within minutes.